835613-40-6

Basic information

• Product Name: (5aS,5bR,8aR,9aR)-7,7-dimethyl-2-phenyl-2,4,5a,5b,8a,9a-hexahydro-5,6,8,9-tetraoxa-1,2-diaza-cyclopenta[b]-as-indacene
• CAS NO: 835613-40-6
• Molecular Weight: 314.341
• Mol File: 835613-40-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (5aS,5bR,8aR,9aR)-7,7-dimethyl-2-phenyl-2,4,5a,5b,8a,9a-hexahydro-5,6,8,9-tetraoxa-1,2-diaza-cyclopenta[b]-as-indacene(CAS DataBase Reference)
• NIST Chemistry Reference: (5aS,5bR,8aR,9aR)-7,7-dimethyl-2-phenyl-2,4,5a,5b,8a,9a-hexahydro-5,6,8,9-tetraoxa-1,2-diaza-cyclopenta[b]-as-indacene(835613-40-6)
• EPA Substance Registry System: (5aS,5bR,8aR,9aR)-7,7-dimethyl-2-phenyl-2,4,5a,5b,8a,9a-hexahydro-5,6,8,9-tetraoxa-1,2-diaza-cyclopenta[b]-as-indacene(835613-40-6)

Safety Data

• Hazardous Substances Data: 835613-40-6(Hazardous Substances Data)

Upstream product

• 582-52-5 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 392712-09-3 (1R)-1-[(3aR,5R,6S,6aR)-2,2-dimethyl-6-(prop-2-yn-1-yloxy)tetrahydro-2H-furo[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol 
• 250662-84-1 (3aR,5S,6S,6aR)-2,2-dimethyl-6-(prop-2-ynyloxy)tetrahydrofuro[2,3-d][1,3]dioxole-5-carbaldehyde 
• 152185-56-3 3-O-Allyl-1,2-O-isopropylidene-α-D-xylo-pentodialdose 
• 67441-18-3 (3aR,4S,5R,6aR)-5-(2,2-dimethyl-[1,3]dioxolan-4R-yl)-2,2-dimethyl-6-prop-2-ynyloxy-tetrahydrofuro[2,3-d][1,3]dioxole 
• 91882-92-7 3-O-allyl-1,2-O-isopropylidene-α-D-glucofuranose 
• 20316-77-2 (3aR,5R,6S,6aR)-6-(allyloxy)-5-((R)-2,2-dimethyl[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydrofuro[2,3-d][1,3]dioxole 
• 835613-36-0 1,2-O-isopropylidene-3-O-allyl-5-aldoglucofuranose phenylhydrazone 

Relevant articles and documents

Cyclization in situ of enose-/ynose-nitrilimines: An expedient approach to the synthesis of chiral glycopyrazoles and pyrazolonucleosides

Intramolecular [3+2] nitrilimine cycloaddition reactions on carbohydrate-derived substrates proceed in a regioselective fashion, affording structurally novel chiral glycopyrazoles (4-6 and 10a-c) in good yields. The products can be subsequently transformed to bicyclic pyrazoles (viz. 11 from 4) or nucleoside analogues (viz. 12 from 4).